Senior Operations Data Analytics Intern

Thermo Fisher Scientific introduces the Thermo Scientific EMPAD G2 electron detector. Monday 31st August 2026 New detector enables faster 4D STEM imaging, helping researchers uncover material properties with greater speed and detail. Thermo Fisher Scientific has introduced the Thermo Scientific(TM) EMPAD(TM) G2 detector, a new detector designed to help researchers see and understand materials in unprecedented detail. EMPAD G2 enables high-speed four-dimensional scanning transmission electron microscopy (4D STEM), an advanced form of electron microscopy that captures far more information about a material than a standard image, helping researchers better understand its structure and properties. "The EMPAD G2 gives scientists a deeper view of materials and the information they need to explore what those materials can do," said Glyn Davies, president, materials and structural analysis, Thermo Fisher Scientific. "By making advanced 4D STEM faster, more reliable and easier to use, we can help researchers accelerate discoveries in areas such as semiconductors, energy and advanced materials - and ultimately enable new technologies that can improve our everyday lives." Capturing weaker signals alongside stronger ones can help researchers measure characteristics, including a material's structure, chemistry, strain and electric and magnetic properties in a single experiment. EMPAD G2 supports advanced applications, ranging from strain mapping and differential phase contrast (DPC) to multi-slice electron ptychography for three-dimensional characterization at the atomic scale. As 4D STEM becomes more widely used in academic and industrial research, detector performance is increasingly important. Researchers need to capture large amounts of information quickly while accurately measuring signals that can range from extremely strong to extremely weak. EMPAD G2 is designed specifically to meet these demands and help researchers get reliable quantitative information from a single acquisition. According to David Muller, Ph.D., Samuel B. Eckert Professor of Engineering at the School of Applied and Engineering Physics at Cornell University, this new technology represents an important milestone for scanning transmission electron microscopy. "The EMPAD G2 project gave us a unique opportunity to design a detector specifically optimized for STEM, rather than TEM or x-ray imaging," said Muller. EMPAD G2 is also fully integrated with the user-friendly Thermo Scientific Velox software. Researchers can collect and analyze multiple types of data, including simultaneous 4D STEM and energy-dispersive x-ray spectroscopy (EDS) within a single workflow. This integration helps simplify advanced materials analysis and supports more reliable, repeatable results. SPONSOR MESSAGE ULVAC plasma ashing systems - high-performance solutions for demanding applications. With over 40 years of experience in plasma ashing, ULVAC offers the ENVIRO series for R&D, pilot lines, and high-volume manufacturing. These systems enable efficient photoresist removal with high flexibility and process versatility. System Variants - ENVIRO-1Xa: Single chamber - ENVIRO-1Xa 2C: Dual chamber - ENVIRO-Optima: Triple chamber Plasma Source Overview - ICP (Inductively Coupled Plasma): High-rate removal, reliable, ideal for MEMS and HDIS - MW (Microwave): Low-temperature polymer removal, ~50% less plasma-induced damage - RF Bias: Complements ICP or MW, enables chemical + physical ashing/etching for advanced processes like anisotropic descum or carbonized layer removal ULVAC Europe - Technology Expertise from Munich Established in 1987, ULVAC GmbH in Munich serves the EMEA region. The portfolio includes vacuum and thin film equipment, analytical tools, and vacuum components such as pumps and leak detectors. ULVAC provides solutions for semiconductors, MEMS, and displays - covering sputtering, etching, ion implantation, ashing, and thermal processes - tailored for R&D, pilot lines, and mass production. Driving Innovation Through Vacuum Technology

Brokerages set Thermo Fisher Scientific Inc. (NYSE:TMO) target price at $619.41. Shares of Thermo Fisher Scientific Inc. (NYSE:TMO - Get Free Report) have earned a consensus recommendation of "Moderate Buy" from the twenty-three analysts that are currently covering the firm, Marketbeat Ratings reports. Six investment analysts have rated the stock with a hold rating, sixteen have assigned a buy rating and one has issued a strong buy rating on the company. The average 1 year price objective among brokerages that have issued ratings on the stock in the last year is $619.4091. Financial Markets News A number of research firms have commented on TMO. Sanford C. Bernstein started coverage on shares of Thermo Fisher Scientific in a research report on Friday, June 26th. They set a "market perform" rating and a $520.00 target price on the stock. Wells Fargo & Company cut their price objective on shares of Thermo Fisher Scientific from $675.00 to $615.00 and set an "overweight" rating on the stock in a report on Friday, May 8th. HSBC lowered Thermo Fisher Scientific from a "buy" rating to a "hold" rating and lowered their target price for the stock from $670.00 to $540.00 in a report on Wednesday, June 3rd. Barclays lifted their price target on Thermo Fisher Scientific from $625.00 to $650.00 and gave the company an "overweight" rating in a report on Friday, July 24th. Finally, Jefferies Financial Group restated a "buy" rating and set a $630.00 price objective on shares of Thermo Fisher Scientific in a research note on Thursday, July 23rd. Key headlines impacting Thermo Fisher Scientific. Discover more Computer Hardware Financial Markets News Here are the key news stories impacting Thermo Fisher Scientific this week: * Thermo Fisher introduced the Thermo Scientific EMPAD G2 electron detector, designed to enable faster, high-speed four-dimensional scanning transmission electron microscopy. The product could support demand for the company's analytical-instrument portfolio and strengthen its position in advanced materials research. * A recent analysis examines whether Isora could provide Thermo Fisher with an additional long-term growth opportunity, potentially broadening the company's exposure to emerging research and laboratory markets. * Thermo Fisher's latest reported quarter showed solid momentum: adjusted EPS of $6.03 exceeded estimates, revenue reached $11.99 billion, and sales increased 10.5% year over year. Fiscal 2026 EPS guidance remains $24.93-$25.33, but much of this strength may already be reflected in the stock's elevated valuation. * Analyst sentiment remains favorable, with a consensus "Moderate Buy" rating, although the average price target of $619.41 is below recent trading levels. Several firms have raised targets toward $650, suggesting optimism but limited upside at the current valuation. * CEO Marc Casper sold 275 shares for approximately $172,000 after selling 10,000 shares worth about $6.3 million earlier in the month. Both transactions were executed under pre-arranged Rule 10b5-1 plans, reducing their significance as a signal of deteriorating fundamentals, but the sales can still weigh on sentiment. Insider activity. In other Thermo Fisher Scientific news, CAO Joseph R. Holmes sold 420 shares of the firm's stock in a transaction that occurred on Friday, August 7th. The shares were sold at an average price of $584.81, for a total value of $245,620.20. Following the completion of the sale, the chief accounting officer directly owned 2,966 shares in the company, valued at $1,734,546.46. This trade represents a 12.40% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Marc N. Casper sold 275 shares of Thermo Fisher Scientific stock in a transaction on Monday, August 24th. The stock was sold at an average price of $627.05, for a total transaction of $172,438.75. Following the completion of the transaction, the chief executive officer directly owned 123,925 shares in the company, valued at $77,707,171.25. This represents a 0.22% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 73,768 shares of company stock valued at $44,122,820 over the last 90 days. 0.33% of the stock is currently owned by corporate insiders. Discover more Company News Stocks & Bonds Institutional trading of Thermo Fisher Scientific. A number of institutional investors have recently made changes to their positions in the business. VELA Investment Management LLC boosted its holdings in Thermo Fisher Scientific by 15.7% in the second quarter. VELA Investment Management LLC now owns 11,167 shares of the medical research company's stock worth $5,599,000 after acquiring an additional 1,513 shares in the last quarter. HighTower Advisors LLC boosted its stake in Thermo Fisher Scientific by 9.8% in the 2nd quarter. HighTower Advisors LLC now owns 159,181 shares of the medical research company's stock worth $79,807,000 after purchasing an additional 14,180 shares in the last quarter. Advus Financial Partners LLC purchased a new stake in Thermo Fisher Scientific during the 2nd quarter worth approximately $250,000. VIRGINIA RETIREMENT SYSTEMS ET Al acquired a new position in Thermo Fisher Scientific during the 2nd quarter valued at approximately $6,969,000. Finally, California State Teachers Retirement System raised its holdings in shares of Thermo Fisher Scientific by 49,331.5% in the second quarter. California State Teachers Retirement System now owns 282,654,735 shares of the medical research company's stock worth $141,711,778,000 after buying an additional 282,082,924 shares during the last quarter. Institutional investors and hedge funds own 89.23% of the company's stock. Thermo Fisher Scientific price performance. Shares of TMO stock opened at $630.66 on Tuesday. The company has a market capitalization of $233.18 billion, a P/E ratio of 33.92, a P/E/G ratio of 2.58 and a beta of 0.85. The company's 50-day simple moving average is $555.52 and its two-hundred day simple moving average is $511.31. Thermo Fisher Scientific has a one year low of $435.27 and a one year high of $647.00. The company has a debt-to-equity ratio of 0.74, a current ratio of 1.55 and a quick ratio of 1.18. Thermo Fisher Scientific (NYSE:TMO - Get Free Report) last posted its quarterly earnings results on Thursday, July 23rd. The medical research company reported $6.03 earnings per share for the quarter, beating the consensus estimate of $5.71 by $0.32. Thermo Fisher Scientific had a net margin of 15.04% and a return on equity of 17.09%. The firm had revenue of $11.99 billion during the quarter, compared to the consensus estimate of $11.71 billion. During the same quarter in the previous year, the firm posted $4.28 earnings per share. The company's revenue was up 10.5% on a year-over-year basis. Thermo Fisher Scientific has set its FY 2026 guidance at 24.930-25.330 EPS. As a group, equities analysts anticipate that Thermo Fisher Scientific will post 25.12 EPS for the current year. Discover more Stocks & Bonds Thermo Fisher Scientific dividend announcement. The company also recently declared a quarterly dividend, which will be paid on Thursday, October 15th. Shareholders of record on Tuesday, September 15th will be given a dividend of $0.47 per share. This represents a $1.88 annualized dividend and a dividend yield of 0.3%. The ex-dividend date of this dividend is Tuesday, September 15th. Thermo Fisher Scientific's dividend payout ratio is presently 10.11%. About Thermo Fisher Scientific. Thermo Fisher Scientific (NYSE: TMO) is a global provider of scientific instrumentation, reagents and consumables, software, and services that support research, clinical, and industrial laboratories. The company supplies analytical instruments and laboratory equipment, life sciences reagents and kits, specialty diagnostics, and a broad range of consumables used by researchers, clinicians, and manufacturers. Its offerings also include laboratory information management and data-analysis software, as well as service solutions such as instrument maintenance, validation, and logistics that help customers run complex workflows efficiently. Financial Markets News Thermo Fisher operates through multiple business areas that broadly cover life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services, including contract development and manufacturing for pharmaceutical and biotechnology companies. Further reading. Receive News & Ratings for Thermo Fisher Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific and related companies with MarketBeat.com's FREE daily email newsletter.

[Sci-Tech NOW] KAIST and Thermo Fisher Scientific sign SHARE Hub autonomous lab partnership. Byeongku Lee 2026.08.27 17:07 KST Korean sci-tech institutes expand AI-driven autonomous labs, research security, and human-AI interaction From left: KAIST President Chul-Young Bae, Dan Shine, Vice President of Thermo Fisher Scientific, and Suk Soo-jin, Head of Thermo Fisher Scientific Korea and Taiwan. Provided by KAIST KAIST announced on the 27th that it signed a business agreement on the 26th with Thermo Fisher Scientific, a laboratory equipment company, to build the next-generation autonomous research hub "SHARE Hub," where AI and robots design and conduct experiments. The SHARE Hub aims to become an autonomous laboratory in which researchers pose scientific questions, AI designs the experiments, robots carry out the experiments, and AI analyzes the results and feeds them into subsequent experiments. KAIST will contribute its research capabilities in life sciences, chemistry, medical science, AI, and robotics, while Thermo Fisher Scientific will provide cutting-edge research equipment along with laboratory automation and system integration capabilities. The two institutions will jointly develop key AI, robotics, and automation technologies required for autonomous laboratories and promote a challenge program to apply and validate these technologies in scientific research and drug discovery grand challenges. KAIST plans to expand the SHARE Hub beyond a facility confined to a specific lab into an open innovation platform where domestic and international companies, universities, research institutes, and hospitals jointly develop and validate new research equipment and AI and robot technologies. Daegu Gyeongbuk Institute of Science and Technology (DGIST) announced on the 27th that it signed a memorandum of understanding (MOU) on the 26th with a branch of the National Intelligence Service to protect research outcomes in cutting-edge technologies such as artificial intelligence (AI) and to create a secure research environment. The agreement was pursued to systematically protect core technologies and critical information generated in research settings and to strengthen capabilities to respond to security threats. The two institutions will cooperate in inspecting security management practices for protecting research outputs and providing cybersecurity consulting, establishing systems for responding to and investigating security incidents, delivering research security training, and reinforcing security measures for foreign researchers participating in national R&D projects. While respecting researchers' autonomy, DGIST plans to expand security education and information sharing tailored to on-site needs, thereby creating an environment where researchers can focus on their work without concerns over technology leakage. Gwangju Institute of Science and Technology (GIST) announced on the 27th that Dr. Moon Jae-young of the AI department, who received his PhD in August, will be appointed as an assistant professor in the HCI Science major at Dongduk Women's University starting in September. Professor Moon's representative work received a Best Paper Award at CHI 2026, the Association for Computing Machinery (ACM) Conference on Human Factors in Computing Systems, a leading international conference in the field of human-computer interaction. He developed a model in which AI infers an overall emotional trajectory based only on memorable moments and moments of significant emotional change, without requiring users to record their emotions at every moment. This approach reduces the time and burden involved in emotion logging while efficiently collecting data needed to understand people's experiences. During his PhD program, Professor Moon conducted joint research with more than six overseas institutions, including the University of Malta and the University of Washington, and gained research and industry experience in game AI and affective computing. Going forward, he plans to study adaptive interaction, trust recovery, and harmful content detection to enable more natural collaboration between humans and AI or robots. 동아시아인 및 디아스포라 <Reference> - doi.org/10.1145/3772318.3791702 How do you feel about this article? 아직 등록된 댓글이 없습니다. Did you enjoy this article? Get more articles via email! Have an interesting science story, whistleblowing material, or tip? Don't hesitate to let Donga Science know.